Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

383 results about "Transcriptional regulation" patented technology

In molecular biology and genetics, transcriptional regulation is the means by which a cell regulates the conversion of DNA to RNA (transcription), thereby orchestrating gene activity. A single gene can be regulated in a range of ways, from altering the number of copies of RNA that are transcribed, to the temporal control of when the gene is transcribed. This control allows the cell or organism to respond to a variety of intra- and extracellular signals and thus mount a response. Some examples of this include producing the mRNA that encode enzymes to adapt to a change in a food source, producing the gene products involved in cell cycle specific activities, and producing the gene products responsible for cellular differentiation in multicellular eukaryotes, as studied in evolutionary developmental biology.

Transcriptional regulatory elements of biological pathways tools, and methods

The present invention provides compositions, kits, assemblies, libraries, arrays, and high throughput methods for large scale structural and functional characterization of gene expression regulatory elements in a genome of an organism, especially in a human genome, that are part of a common pathway. In one aspect of the invention, an array of expression constructs is provided, each of the expression constructs comprising: a nucleic acid segment operably linked with a reporter sequence in an expression vector such that expression of the reporter sequence is under the transcriptional control of the nucleic acid segment. The present invention can have a wide variety of applications such as in personalized medicine, pharmacogenomics, and correlation of polymorphisms with phenotypic traits.
Owner:SWITCHGEAR GENOMICS

Methods of treating cancer using a heat shock factor activity inhibitor

A disease treatment is provided by controlling the expression of a protein induced by a heat shock factor.The novel compound benzo-1,3-dioxole provides an inhibitor of HSF activity or an inhibitor of inducing the production of a protein regulated by HSF, which inhibits the activity of a heat shock factor, a transcriptional regulatory factor, thereby in turn inhibiting transcription of a structural gene having a heat shock element sequenc in the gene region for transcriptional regulation into RNA, and thus inhibiting translation of the gene into a protein, and resulting in inhibition of inducing production of RNA or protein encoded by the gene. It also provides a drug for treating or preventing cancer through thermotherapy and a drug for treating or preventing stress diseases such as depression.
Owner:KANEKA CORP

Ligand activated transcriptional regulator proteins

InactiveUS7329728B1Avoid undesirable immunological responseFungiPeptide/protein ingredientsNucleotideBinding domain
Fusion proteins for use as ligand-dependent transcriptional regulators are provided. The fusion proteins include a nucleotide binding domain operatively linked to a ligand-binding domain. They also can include a transcription regulating domain. The nucleotide binding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotide sequence of from 3 to about 18 nucleotides are provided. The fusion proteins are used for gene therapy. Also provided are polynucleotides encoding the fusion proteins, expression vectors, and transfected cells.
Owner:THE SCRIPPS RES INST +1

Pichia yeast expression system without carbon source repression, and establishing method and applications

The invention relates to an enhanced methylotrophic pichia yeast expression system without carbon source repression, and an establishing method and applications, wherein the pichia yeast expression system is high in expression amount. The invention discloses a method capable of eliminating methanol inducible promoter single methanol carbon source dependence and carbon source severe repression; artificial modification of the transcription regulation and control heredity route in methylotrophic yeast cells is adopted, promoter transcription intensity is increased, and the regulation and controlmode is changed. The yeast expression system and the expression method disclosed in the invention are capable of eliminating dependence of promoters which are dependent on methanol induction and are influenced by carbon source repression on methanol, so that high efficiency expression of exogenous polypeptides can be realized at other carbon source conditions, the highest expression amount is 5 times of that of wild type AOX1 promoter at methanol conditions.
Owner:EAST CHINA UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products